Bill Text: NY S01530 | 2019-2020 | General Assembly | Introduced
Bill Title: Requires disclosure of addiction risks for certain prescription drugs; requires physicians, nurses and pharmacists to provide information on prevention, mitigation and treatment of prescription drug addiction and to have the patient sign a form acknowledging education of such risks.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced - Dead) 2020-01-08 - REFERRED TO HEALTH [S01530 Detail]
Download: New_York-2019-S01530-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 1530 2019-2020 Regular Sessions IN SENATE January 15, 2019 ___________ Introduced by Sens. KENNEDY, KRUEGER -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law and the mental hygiene law, in relation to requiring disclosure of addiction risks for certain prescription drugs The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. This act shall be known and may be cited as the "Michael 2 David Israel patient information act". 3 § 2. The public health law is amended by adding a new section 3317 to 4 read as follows: 5 § 3317. Required disclosures. 1. Definitions. For purposes of this 6 section: 7 (a) "opiate analgesics" shall mean the medicines buprenorphine, butor- 8 phanol, codeine, hydrocodone, hydromorphone, levorphanol, meperidine, 9 methadone, morphine, nalbuphine, oxycodone, oxymorphone, pentazocine and 10 propoxyphene as well as their brand names, isomers and combinations. 11 (b) "psychotropic drugs" shall mean any drug or medicine that affects 12 mental activity, behavior or perception including anti-psychotics, anti- 13 depressants, anti-anxiety drugs or anxiolytics and hypnotics. 14 2. Disclosures. Whenever a practitioner, pharmacist, registered nurse 15 or any other person who is authorized to distribute substances regulated 16 by this article, dispenses opiate analgesics or psychotropic drugs such 17 prescribing physician, nurse or pharmacist shall: 18 (a) describe the risks of addiction to the patient; 19 (b) after consulting the patient's medical history, inform the patient 20 of his or her chance of addiction; 21 (c) provide the patient with information about coping with opiate 22 analgesic or pyschotropic drug addiction and available local resources 23 including detoxification centers, counseling services and hotlines; and EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD02059-01-9S. 1530 2 1 (d) have the patient sign a form approved by the department acknowl- 2 edging that he or she has been informed of the prevention, mitigation 3 and treatment of such addiction. 4 3. Enforcement by department. (a) The department shall be responsible 5 for publishing informational pamphlets regarding the dangers of opiate 6 analgesics and psychotropic drugs and distribution. Such pamphlets shall 7 take the form prescribed by the commissioner. The department shall also 8 provide the form required in paragraph (d) of subdivision two of this 9 section. 10 (b) The department shall be responsible for the receipt, investigation 11 and substantiation of any complaints or tips about physicians, nurses or 12 pharmacists who fail to provide the information mandated in this 13 section. Failure to provide such information shall be punishable as 14 follows: 15 (i) First offense; fine of up to one thousand dollars; 16 (ii) Second offense: fine of up to five thousand dollars; 17 (iii) Third offense: suspension of license up to six months; 18 (iv) Fourth offense: suspension of license up to one year; 19 (v) Fifth offense: permanent suspension or revocation of license and 20 referred to the respective licensing boards under this article. 21 A signed patient form shall be prima facie proof that the person 22 prescribing such medications has complied with the provisions of this 23 section. 24 § 3. The mental hygiene law is amended by adding a new section 19.18-c 25 to read as follows: 26 § 19.18-c Required disclosures. 27 (a) Definitions. For purposes of this section: 28 (1) "department" shall mean the department of health. 29 (2) "opiate analgesics" shall mean the medicines buprenorphine, butor- 30 phanol, codeine, hydrocodone, hydromorphone, levorphanol, meperidine, 31 methadone, morphine, nalbuphine, oxycodone, oxymorphone, pentazocine and 32 propoxyphene as well as their brand names, isomers and combinations. 33 (3) "psychotropic drugs" shall mean any drug or medicine that affects 34 mental activity, behavior or perception including anti-psychotics, anti- 35 depressants, anti-anxiety drugs or anxiolytics and hypnotics. 36 (b) Disclosures. Whenever a practitioner, pharmacist, registered nurse 37 or any other person who is authorized to distribute substances regulated 38 by this article or those regulated under article thirty-three of the 39 public health law, dispenses opiate analgesics or psychotropic drugs, 40 such prescribing physician, nurse or pharmacist shall: 41 (1) describe the risks of addiction to the patient; 42 (2) after consulting the patient's mental history, inform the patient 43 of his or her chance of addiction; 44 (3) provide the patient with information about coping with opiate 45 analgesic or psychotropic drug addiction and available local resources 46 including detoxification centers, counseling services and hotlines; and 47 (4) have the patient sign a form approved by the department acknowl- 48 edging that he or she has been informed of the prevention, mitigation 49 and treatment of such addiction. 50 (c) Enforcement by department. (1) The department shall be responsible 51 for publishing informational pamphlets regarding the dangers of opiate 52 analgesics and psychotropic drugs for distribution. Such pamphlets shall 53 take the form prescribed by the commissioner of health. The department 54 shall also provide the form required in paragraph four of subdivision 55 (b) of this section.S. 1530 3 1 (2) The department shall be responsible for the receipt, investigation 2 and substantiation of any complaints or tips about physicians, nurses or 3 pharmacists who fail to provide the information mandated in this 4 section. Failure to provide such information shall be punishable as 5 follows: 6 (i) First offense: fine of up to one thousand dollars; 7 (ii) Second offense: fine of up to five thousand dollars; 8 (iii) Third offense: suspension of license up to six months; 9 (iv) Fourth offense: suspension of license up to one year; 10 (v) Fifth offense: permanent suspension or revocation of license and 11 referred to the respective licensing boards under article thirty-three 12 of the public health law. 13 A signed patient form shall be prima facie proof that the person 14 prescribing such medications has complied with the provisions of this 15 section. 16 § 4. This act shall take effect immediately.
